You searched for "malignancy"
20th ASEAN ORL-HNS Congress
Amrita Bhattacharya, Second Year Post-Graduate Trainee, Department of ENT Head & Neck Surgery, Ramakrishna Mission Seva Pratishthan, Vivekananda Institute of Medical Sciences, Kolkata, India and Miss Rajini Rajagopal, Locum Consultant ENT Surgeon, UK. A pre-congress course on rhinology kicked things...The integration of targeted therapy and surgery in advanced thyroid cancer clinical trials
One of the headline speakers, Mark Zafereo, will be talking at IFOS about thyroid cancer. We hear from his team about some of the areas they will be discussing. Locally advanced thyroid cancer generally refers to patients who have significant...Muscle tension dysphagia: an underdiagnosed problem
In this article, the authors introduce the description of swallowing problems which have been recently attributed to muscle tension dysphagia (MTDg). The authors are clear that this is a diagnosis of exclusion, and it is important to rule out other...Developing ENT services in Zambia
Lufunda Lukama and Matthew Clark. Lufunda Lukama is an ENT surgeon in Zambia. In a country of 19.6 million, he is one of five such specialists. It is not difficult to see the problem that he, and the country as...In conversation with Liam M Flood: Middlesbrough (M for Michael? ...nope, Martin!)
Liam Flood. With a name such as Liam you must have some ‘Irish blood’? Where does your family come from? Tell us more? (What did your old man / mum do?) Some Irish blood? Those who know me well would...Systemic agents in thyroid cancer
For those patients who have disseminated or unresectable thyroid cancer, Dr Arabella Hunt and Dr Kate Newbold review systemic treatments, their differences, toxicities and outcomes. Thyroid cancer is the most common endocrine malignancy. It is subdivided into differentiated (papillary, follicular...
